Skip to main content

RA Capital Management — Portfolio, Page 12

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

453
Companies
$44.2B
Total invested
$123.1M
Avg. check
18
Industries
Biotechnology 19Health Care 15Therapeutics 9Pharmaceutical 8Medical 8Biopharma 7+12 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 265288 of 453
Apeiron labs
February 2026

Apeiron labs mission is to provide data from the upper of the ocean.

Analytics · Cambridge$9.5M Series A
Avalanche Energy
February 2026

Avalanche Energy is a fusion energy startup that develops micro-fusion reactors for distributed energy and mobility.

Electrical Distribution · Seattle$29.0M Series Unknown
Vaxcyte
January 2026

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Biopharma · San Carlos$632.5M Post Ipo Equity
Nautilus Biotechnology
January 2026

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

Biotechnology · San Carlos$1.6M Grant
CORXEL Pharmaceuticals
January 2026

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Biotechnology · Shanghai$287.0M Series D
BioAge Labs
January 2026

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Biopharma · Richmond$115.0M Post Ipo Equity
Kinaset Therapeutics
January 2026

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Health Care · Boston$103.0M Series B
Century Therapeutics
January 2026

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Biotechnology · Philadelphia$135.0M Post Ipo Equity
Parabilis Medicines
January 2026

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Biopharma · Cambridge$305.0M Series F
Diagonal Therapeutics
January 2026

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Biopharma · Watertown$125.0M Series B
EvodiaBio
December 2025

EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries.

Biotechnology · Copenhagen$7.1M Series Unknown
Jade Biosciences
December 2025

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health Care · Waltham$45.0M Post Ipo Equity
Ambros Therapeutics
December 2025

Ambros Therapeutics is a clinical-stage biotechnology company.

Biotechnology · Irvine$125.0M Series A
Tenaya Therapeutics
December 2025

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Biopharma · San Francisco$60.0M Post Ipo Equity
Wave Life Sciences
December 2025

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Biotechnology · Boston$350.0M Post Ipo Equity
Sidera Bio
December 2025

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Genetics · Copenhagen$109.0M Series A
Dyne Therapeutics
December 2025

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Biotechnology · Cambridge$402.5M Post Ipo Equity
Triana Biomedicines
December 2025

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Biopharma · Lexington$120.0M Series B
Belite Bio
December 2025

Belite Bio is a clinical stage biopharmaceutical drug development company.

Biotechnology · San Diego$350.0M Post Ipo Equity
Artios Pharma
November 2025

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Biopharma · Cambridge$115.0M Series D
Freenome
November 2025

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Biotechnology · South San Francisco$75.0M Corporate Round
Imbria Pharmaceuticals
November 2025

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Biotechnology · BostonSeries B
Invivyd
November 2025

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Biotechnology · Waltham$125.0M Post Ipo Equity
Bambusa Therapeutics
November 2025

Bambusa Therapeutics operates as biotechnology company.

Biotechnology · BostonSeries A

Where RA Capital Management invests

Biotechnology19
Health Care15
Therapeutics9
Pharmaceutical8
Medical8
Biopharma7

About RA Capital Management's portfolio

How many companies has RA Capital Management invested in?

RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does RA Capital Management invest in?

RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 18 different industry categories.

What is RA Capital Management's largest investment?

Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $44.2B.

What is the average investment size for RA Capital Management?

RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.

What are RA Capital Management's most recent investments?

Recent RA Capital Management portfolio additions include Apeiron labs, Avalanche Energy, Vaxcyte, Nautilus Biotechnology, CORXEL Pharmaceuticals. These companies were founded in 2020 or later.

Reach the founders behind these 453 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →